A Single Dose of Pembrolizumab in HIV-Infected People
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Breast Cancer Study of Preoperative Pembrolizumab + Radiation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002)
- Status
- COMPLETED
- Phase
- PHASE1
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)
- Status
- COMPLETED
- Phase
- PHASE3
Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
- Status
- COMPLETED
- Phase
- PHASE3
DPX-Survivac and Checkpoint Inhibitor in DLBCL
- Status
- COMPLETED
- Phase
- PHASE2
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
- Status
- COMPLETED
- Phase
- PHASE1
Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab as Neoadjuvant Treatment in HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1